IN2012DN02828A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02828A IN2012DN02828A IN2828DEN2012A IN2012DN02828A IN 2012DN02828 A IN2012DN02828 A IN 2012DN02828A IN 2828DEN2012 A IN2828DEN2012 A IN 2828DEN2012A IN 2012DN02828 A IN2012DN02828 A IN 2012DN02828A
- Authority
- IN
- India
- Prior art keywords
- vildagliptin
- complexes
- present
- amorphous
- high purity
- Prior art date
Links
- SYOKIDBDQMKNDQ-XWTIBIIYSA-N vildagliptin Chemical class C1C(O)(C2)CC(C3)CC1CC32NCC(=O)N1CCC[C@H]1C#N SYOKIDBDQMKNDQ-XWTIBIIYSA-N 0.000 abstract 7
- 229960001254 vildagliptin Drugs 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 2
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0900638A HUP0900638A2 (en) | 2009-10-07 | 2009-10-07 | Adducts of inorganic salts basea on vildaelitpin applicable for preparation of pharmaceutical compositions |
| PCT/HU2010/000106 WO2011042765A1 (fr) | 2009-10-07 | 2010-10-07 | Complexes de sel inorganique de vildaglipdine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN02828A true IN2012DN02828A (fr) | 2015-07-24 |
Family
ID=89989301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2828DEN2012 IN2012DN02828A (fr) | 2009-10-07 | 2010-10-07 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8877799B2 (fr) |
| EP (1) | EP2486008B1 (fr) |
| CN (1) | CN102656144A (fr) |
| BR (1) | BR112012008007A2 (fr) |
| CA (1) | CA2776005A1 (fr) |
| EA (1) | EA021810B1 (fr) |
| HU (1) | HUP0900638A2 (fr) |
| IN (1) | IN2012DN02828A (fr) |
| WO (1) | WO2011042765A1 (fr) |
| ZA (1) | ZA201202464B (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU231050B1 (hu) | 2010-08-19 | 2020-02-28 | Egis Gyógyszergyár Nyrt. | Eljárás gyógyszerhatóanyag előállítására |
| CN103724248B (zh) * | 2014-01-16 | 2018-07-27 | 万全万特制药江苏有限公司 | 维格列汀工艺杂质的制备方法 |
| CN104644582A (zh) * | 2014-12-14 | 2015-05-27 | 天津市康瑞药业有限公司 | 维格列汀滴丸及其制备方法 |
| CN105330580B (zh) * | 2015-10-27 | 2017-12-12 | 石家庄康贺威药业有限公司 | 一种维格列汀化合物及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| GB0308854D0 (en) * | 2003-04-16 | 2003-05-21 | Novartis Ag | Organic compounds |
| AR044019A1 (es) * | 2003-04-16 | 2005-08-24 | Novartis Ag | Proceso para la preparacion de 2-cianopirrolidinas n-sustituidas |
| MX2008001609A (es) * | 2005-08-04 | 2008-02-19 | Novartis Ag | Sales de vildagliptina. |
| WO2008084383A2 (fr) | 2007-01-10 | 2008-07-17 | Medichem, S.A. | Procédé de préparation de la vildagliptine |
-
2009
- 2009-10-07 HU HU0900638A patent/HUP0900638A2/hu not_active IP Right Cessation
-
2010
- 2010-10-07 BR BR112012008007A patent/BR112012008007A2/pt not_active IP Right Cessation
- 2010-10-07 EA EA201290156A patent/EA021810B1/ru not_active IP Right Cessation
- 2010-10-07 EP EP10773700.9A patent/EP2486008B1/fr active Active
- 2010-10-07 IN IN2828DEN2012 patent/IN2012DN02828A/en unknown
- 2010-10-07 WO PCT/HU2010/000106 patent/WO2011042765A1/fr active Application Filing
- 2010-10-07 CA CA2776005A patent/CA2776005A1/fr not_active Abandoned
- 2010-10-07 US US13/500,356 patent/US8877799B2/en not_active Expired - Fee Related
- 2010-10-07 CN CN2010800493564A patent/CN102656144A/zh active Pending
-
2012
- 2012-04-04 ZA ZA2012/02464A patent/ZA201202464B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0900638A2 (en) | 2011-05-30 |
| ZA201202464B (en) | 2013-06-26 |
| CA2776005A1 (fr) | 2011-04-14 |
| US20130005790A1 (en) | 2013-01-03 |
| US8877799B2 (en) | 2014-11-04 |
| WO2011042765A1 (fr) | 2011-04-14 |
| BR112012008007A2 (pt) | 2016-04-05 |
| EA201290156A1 (ru) | 2012-11-30 |
| HU0900638D0 (en) | 2010-03-01 |
| CN102656144A (zh) | 2012-09-05 |
| EA021810B1 (ru) | 2015-09-30 |
| EP2486008A1 (fr) | 2012-08-15 |
| WO2011042765A8 (fr) | 2012-06-14 |
| EP2486008B1 (fr) | 2015-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20125579B (en) | Novel crystalline form vi of agomelatine, preparation method thereof and pharmaceutical compositions containing same | |
| UA83718C2 (ru) | Кристаллическая форма iv агомелатина, способ ее получения и фармацевтическая композиция, которая ее содержит | |
| TW200716511A (en) | New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it | |
| HK1149258A1 (en) | Compounds | |
| GEP20105086B (en) | Potassium salt of an hiv integrase inhibitor | |
| NZ590334A (en) | ICOTINIB HYDROCHLORIDE (4-[(3-ethynylphenyl)amino]-6,7-benzo-12-crownquinazoline hydrochloride), SYNTHESIS, CRYSTALLOGRAPHIC FORM, MEDICAL COMBINATION, AND USES THEREOF | |
| MX2011011661A (es) | Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750. | |
| TW201204363A (en) | Certain amino-pyrimidines, compositions thereof, and methods for their use | |
| MY160460A (en) | Agomelatine hydrochloride hydrate and preparation thereof | |
| GEP20094576B (en) | New cyrstalline form iii of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
| PT2323972E (pt) | Compostos de tetraciclina substituídos com c7-flúor | |
| IN2012DN02502A (fr) | ||
| MX2010009022A (es) | Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso. | |
| PH12015502429A1 (en) | Dicarboxylic acid compound | |
| MX2012002597A (es) | Nuevos inhibidores de la lipasa sensible a las hormonas (hsl) utiles para el tratamiento de la diabetes. | |
| IN2012DN02828A (fr) | ||
| IN2012DN01292A (fr) | ||
| MY161749A (en) | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | |
| MY147951A (en) | Crystalline potassium salt of lipoxin a? analogs | |
| MX2013002620A (es) | Novedosas n-hidroxi-benzamidas para el tratamiento del cancer. | |
| MX2012000685A (es) | Compuesto de 3-fenoximetilpirrolidina. | |
| MY195576A (en) | Novel Amino-Imidazopyridine Derivatives as Janus Kinase Inhibitors and Pharmaceutical use Thereof | |
| MX2009012518A (es) | Derivados de piperidina 4,4-disubstituidos. | |
| MY157492A (en) | Pharmaceutical composition 271 | |
| MX2013000294A (es) | Intermedios y procedimiento de preparación de un inhibidor específico de la trombina. |